# ALK-Abello, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/alk-abello-inc/b626f86d-b379-45aa-96d2-0661e9d1c981

> Inspection records and compliance data for ALK-Abello, Inc. in Plainville, Connecticut. Access full analysis and detailed observations.

---

## Details

- Name: ALK-Abello, Inc.
- FEI Number: 3006900385
- City: Plainville
- State: Connecticut
- Country Name: United States
- Address Line 1: 10 Farmington Valley Dr Ste 106
- Zip Code: 06062

## Related Documents

- [483 - ALK-Abello, Inc. - 2025-06-13](https://www.keypedia.com/records/483/alk-abello-inc/37e6bb23-c272-4afe-9175-6eb3395c8e4d) — source: FDA, date: June 13, 2025
- [FDA Inspection 1272585 - ALK-Abello, Inc. - 2025-06-13](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/98ee1973-75cc-4327-999a-3c171b59a60e) — classification: Official Action Indicated (OAI), source: FDA, date: June 13, 2025
- [483 - ALK-Abello, Inc. - 2025-06-03](https://www.keypedia.com/records/483/alk-abello-inc/d0808837-16a8-47e3-b918-38c18212a872) — source: FDA, date: June 3, 2025
- [483 - ALK-Abello, Inc. - 2022-10-21](https://www.keypedia.com/records/483/alk-abello-inc/28026031-bf91-4f0d-80bc-dc0f6eb47d03) — source: FDA, date: October 21, 2022
- [FDA Inspection 1181903 - ALK-Abello, Inc. - 2022-10-21](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/f9449cbf-9c0e-45df-b654-e114b0c31e5b) — classification: Official Action Indicated (OAI), source: FDA, date: October 21, 2022
- [483 - ALK-Abello, Inc. - 2021-05-03](https://www.keypedia.com/records/483/alk-abello-inc/8ce8e894-4216-4266-9ef9-6d24167cfebd) — source: FDA, date: May 3, 2021
- [FDA Inspection 1141073 - ALK-Abello, Inc. - 2021-05-03](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/1c5959f1-bf4d-46cd-8525-7f6a43ee6377) — classification: Official Action Indicated (OAI), source: FDA, date: May 3, 2021
- [483 - ALK-Abello, Inc. - 2019-03-01](https://www.keypedia.com/records/483/alk-abello-inc/0609b146-1f6d-4543-818a-1f9d5f84cd68) — source: FDA, date: March 1, 2019
- [FDA Inspection 1073636 - ALK-Abello, Inc. - 2018-11-29](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/b9f8cb7a-b9a6-4a9f-a96c-051c1487eb36) — classification: No Action Indicated (NAI), source: FDA, date: November 29, 2018
- [FDA Inspection 1025749 - ALK-Abello, Inc. - 2017-09-19](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/12c0df79-0a83-4db5-b991-5f2138dedd10) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2017
- [FDA Inspection 892618 - ALK-Abello, Inc. - 2014-08-26](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/76e0bd39-fd32-4a77-98ac-98f80643373f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2014
- [FDA Inspection 813064 - ALK-Abello, Inc. - 2012-12-19](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/ca08361f-e650-42af-95b7-b04fa0e883d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2012
- [FDA Inspection 781640 - ALK-Abello, Inc. - 2012-05-18](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/35ea4a69-4d98-4830-87a5-114ae8311c2e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 18, 2012
- [FDA Inspection 604459 - ALK-Abello, Inc. - 2009-08-06](https://www.keypedia.com/records/fda_inspections/alk-abello-inc/158d26d3-56df-46cc-8571-83f8f1645c7c) — classification: No Action Indicated (NAI), source: FDA, date: August 6, 2009

## Related Companies

- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Zoetis LLC](https://www.keypedia.com/companies/zoetis-llc/1ea95bb9-fb5b-458d-bfff-ca0195c13aa6)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92)
- [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369)
- [Biological E. Limited](https://www.keypedia.com/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [Hospira Zagreb d.o.o.](https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)
- [Pharmaron Shaoxing Co., Ltd](https://www.keypedia.com/companies/pharmaron-shaoxing-co-ltd/46e46053-2a60-4ce8-9f9f-b4fe235c95f9)
- [Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)](https://www.keypedia.com/companies/daewoong-pharmaceutical-co-ltd-hyangnam-factory/2f9e6a6a-9f69-4377-b1ef-5500338ce477)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)

## Related Officers

- [Jonah S Offerjost](https://www.keypedia.com/people/jonah-s-offerjost/66afe9d0-ba7f-467d-b7bf-a83cc02b1d1e)
- [Investigator](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Investigator](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)
- [Deputy Director](https://www.keypedia.com/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)